advertisement

Topcon

Lu DW 7

Showing records 1 to 7 | Display all abstracts from Lu DW

73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Lin CW
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51
73197 Sumatriptan-induced angle-closure glaucoma: A case report
Hsu CR; Chen YH
Medicine 2017; 96: e6953
73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Sherman B
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51
73197 Sumatriptan-induced angle-closure glaucoma: A case report
Tai MC
Medicine 2017; 96: e6953
73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Moore LA
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51
73197 Sumatriptan-induced angle-closure glaucoma: A case report
Lu DW
Medicine 2017; 96: e6953
73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Laethem CL; Lu DW; Pattabiraman PP; Rao PV; deLong MA; Kopczynski CC
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51

Issue 18-4

Change Issue


advertisement

WGA Rescources